Nasu M - Search Results

1

Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy.

Murakami K, Fujioka T, Okimoto T, Sato R, Kodama M, Nasu M. Murakami K, et al. Among authors: nasu m. Int J Antimicrob Agents. 2002 Jan;19(1):67-70. doi: 10.1016/s0924-8579(01)00456-3. Int J Antimicrob Agents. 2002. PMID: 11814770

2

[Drug sensitivity test for Helicobacter pylori].

Murakami K, Nasu M. Murakami K, et al. Among authors: nasu m. Nihon Rinsho. 2002 Feb;60 Suppl 2:350-3. Nihon Rinsho. 2002. PMID: 11979806 Review. Japanese. No abstract available.

3

[Minocycline-containing eradication therapy for patients with clarithromycin-resistant Helicobacter pylori infection].

Sato R, Murakami K, Okimoto T, Ishitobi H, Nasu M. Sato R, et al. Among authors: nasu m. Nihon Rinsho. 2002 Feb;60 Suppl 2:449-51. Nihon Rinsho. 2002. PMID: 11979825 Review. Japanese. No abstract available.

4

[Clarithromycin (CAM)].

Murakami K, Nasu M. Murakami K, et al. Among authors: nasu m. Nihon Rinsho. 2002 Feb;60 Suppl 2:667-70. Nihon Rinsho. 2002. PMID: 11979867 Review. Japanese. No abstract available.

5

Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan.

Okimoto T, Murakami K, Sato R, Miyajima H, Nasu M, Kagawa J, Kodama M, Fujioka T. Okimoto T, et al. Among authors: nasu m. Helicobacter. 2003 Jun;8(3):186-91. doi: 10.1046/j.1523-5378.2003.00143.x. Helicobacter. 2003. PMID: 12752730

6

Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection.

Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Fujioka T, Kodama M, Kagawa J. Murakami K, et al. Among authors: nasu m. J Gastroenterol. 2003;38(10):937-41. doi: 10.1007/s00535-003-1176-x. J Gastroenterol. 2003. PMID: 14614600 Clinical Trial.

7

Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura.

Sato R, Murakami K, Watanabe K, Okimoto T, Miyajima H, Ogata M, Ohtsuka E, Kodama M, Saburi Y, Fujioka T, Nasu M. Sato R, et al. Among authors: nasu m. Arch Intern Med. 2004 Sep 27;164(17):1904-7. doi: 10.1001/archinte.164.17.1904. Arch Intern Med. 2004. PMID: 15451766 Clinical Trial.

8

Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice.

Watanabe K, Murakami K, Sato R, Kashimura K, Miura M, Ootsu S, Miyajima H, Nasu M, Okimoto T, Kodama M, Fujioka T. Watanabe K, et al. Among authors: nasu m. Antimicrob Agents Chemother. 2004 Dec;48(12):4582-8. doi: 10.1128/AAC.48.12.4582-4588.2004. Antimicrob Agents Chemother. 2004. PMID: 15561829 Free PMC article.

9

Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa.

Kodama M, Fujioka T, Murakami K, Okimoto T, Sato R, Watanabe K, Nasu M. Kodama M, et al. Among authors: nasu m. J Gastroenterol Hepatol. 2005 Jun;20(6):941-6. doi: 10.1111/j.1440-1746.2005.03880.x. J Gastroenterol Hepatol. 2005. PMID: 15946145

10

Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.

Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Fujioka T, Kodama M, Abe T, Sato S, Arita T. Murakami K, et al. Among authors: nasu m. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):262-7. doi: 10.1111/j.1440-1746.2006.04183.x. J Gastroenterol Hepatol. 2006. PMID: 16460484 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

868 results

Search Page